large neurotensin



large neurotensin

D1DD1S2SS2E3EE3E4EE4E5EE5M6MM6K7KK7A8AA8L9LL9E10EE10A11AA11D12DD12F13FF13L14LL14T15TT15N16NN16M17MM17H18HH18T19TT19S20SS20K21KK21I22II22S23SS23K24KK24A25AA25H26HH26V27VV27P28PP28S29SS29W30WW30K31KK31M32MM32T33TT33L34LL34L35LL35N36NN36V37VV37C38CC38S39SS39L40LL40V41VV41N42NN42N43NN43L44LL44N45NN45S46SS46P47PP47... and 94 more residue(s)...... and 94 more residue(s)

SMILES None
InChIKey None
Sequence DSEEEMKALEADFLTNMHTSKISKAHVPSWKMTLLNVCSLVNNLNSPAEETGEVHEEELVARRKLPTALDGFSLEAMLTIYQLHKICHSRAFQHWELIQEDILDTGNDKNGKEEVIKRKIPYILKRQLYENKPRRPYILKR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

large neurotensin

D1DD1S2SS2E3EE3E4EE4E5EE5M6MM6K7KK7A8AA8L9LL9E10EE10A11AA11D12DD12F13FF13L14LL14T15TT15N16NN16M17MM17H18HH18T19TT19S20SS20K21KK21I22II22S23SS23K24KK24A25AA25H26HH26V27VV27P28PP28S29SS29W30WW30K31KK31M32MM32T33TT33L34LL34L35LL35N36NN36V37VV37C38CC38S39SS39L40LL40V41VV41N42NN42N43NN43L44LL44N45NN45S46SS46P47PP47... and 94 more residue(s)...... and 94 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.